We are live on ! Find out more
UONDDL

University of Notre Dame du Lac Portfolio holdings

AUM $66.8M
1-Year Est. Return 43.52%
This Fund
S&P 500
This Quarter Est. Return
+11.21%
1 Year Est. Return
+43.52%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$97.7M
AUM Growth
+$14M
Cap. Flow
+$7.96M
Cap. Flow %
8.15%
Top 10 Hldgs %
100%
Holding
2
New
1
Increased
–
Reduced
–
Closed
–

Top Buys

Rank Stock Value
1
SYRE icon
Spyre Therapeutics
SYRE
+$7.96M

Top Sells

No sells this quarter

Sector Composition

Rank Sector Weight
1 Financials 87.27%
2 Healthcare 12.73%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
BRK.B icon
1
Berkshire Hathaway Class B
BRK.B
$1.11T
$85.3M 87.27%
239,031
– –
SYRE icon
2
Spyre Therapeutics
SYRE
$9B
$12.4M 12.73%
+577,616
New +$7.96M

Similar funds

PPL
PATRIZIA Pty Ltd Barton, Australia $67.3M AUM 26.18% 1-Year Est. Return
ACH
Avista Capital Holdings New York $68.4M AUM 23% 1-Year Est. Return
TM
Titan Managers Scottsdale, Arizona $63.6M AUM 0.03% 1-Year Est. Return
SVG
Sun Valley Gold Sun Valley, Idaho $63.2M AUM 182.76% 1-Year Est. Return
DLDF
Dan L. Duncan Foundation Houston, Texas $70.6M AUM 22.88% 1-Year Est. Return
AGFIA
Accel Growth Fund IV Associates Palo Alto, California $58.7M AUM 25.19% 1-Year Est. Return
ARC
Arias Resource Capital George Town, Grand Cayman, Cayman Islands $58.6M AUM 26.15% 1-Year Est. Return
ST
SAL Trading Bala Cynwyd, Pennsylvania $57M AUM 33.89% 1-Year Est. Return

University of Notre Dame du Lac's Q4 2023 Portfolio in Review

As of Q4 2023, University of Notre Dame du Lac held 2 positions worth $97.7M, up 17% from $83.7M the previous quarter. Its ten largest holdings account for 100% of the portfolio.

University of Notre Dame du Lac deployed $7.96M of net new capital in Q4 2023, opening 1 new position. Its largest new stake was Spyre Therapeutics: 577,616 shares worth $12.4M.

By sector, the portfolio is most concentrated in Financials at 87% of assets, down from 100% a quarter earlier, followed by Healthcare.

  • University of Notre Dame du Lac's largest Q4 2023 buy was Spyre Therapeutics: 577,616 shares worth $12.4M.
  • University of Notre Dame du Lac's ten largest holdings make up 100% of its $97.7M portfolio in Q4 2023.
  • University of Notre Dame du Lac opened 1 new position and closed 0 in Q4 2023.
  • University of Notre Dame du Lac's portfolio value rose 17% quarter-over-quarter to $97.7M.

Based on University of Notre Dame du Lac's 13F filing for Q4 2023, filed 13 Feb 2024.